A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure

Journal of Clinical Psychiatry

Volumn 72, Issue 7, 2011, Pages 1002-1007

  Suri, Rita ^a   Hellemann, Gerhard ^a   Stowe, Zachary N ^b   Cohen, Lee S ^c   Aquino, Ana ^a   Altshuler, Lori L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; SERTRALINE;

ADULT; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BRAZELTON NEONATAL BEHAVIORAL ASSESSMENT SCALE; CHILD HEALTH; COGNITION; CONTROLLED STUDY; DELIVERY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG SAFETY; FEMALE; HAMILTON SCALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MATERNAL TREATMENT; NATURALISTIC INQUIRY; NEWBORN; OUTCOME ASSESSMENT; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; SEX DIFFERENCE;

ADULT; ANTIDEPRESSIVE AGENTS; CHILD DEVELOPMENT; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INFANT; INFANT BEHAVIOR; INFANT, NEWBORN; MALE; NEUROLOGIC EXAMINATION; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK FACTORS;

EID: 79960747382     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10m06135     Document Type: Article

References (25)

1. Weissman MM. Advances in psychiatric epidemiology: rates and risks for major depression. Am J Public Health. 1987;77(4):445-451. doi:10.2105/AJPH.7.4. 45 PubMed (Pubitemid 17044058)
2. O'Hara MW, Zekoski EM, Philipps LH, et al. Controlled prospective study of postpartum mood disorders: comparison of childbearing and nonchildbearing women. J Abnorm Psychol. 1990;99(1):3-15. doi:10.1037/021-843X.9.1.3 PubMed (Pubitemid 20117081)
3. Marcus SM, Flynn HA, Blow FC, et al. Depressive symptoms among pregnant women screened in obstetrics settings. J Womens Health (Larchmt). 2003;12(4):373-380. doi:10.1089/1540903765480 PubMed (Pubitemid 36701614)
4. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295(5):499-507. doi:10.101/jama.295.5.49 PubMed (Pubitemid 43200344)
5. Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004;191(2):398-407. doi:10.1016/j.ajog.204.04. 025 PubMed (Pubitemid 39178690)
6. Heikkinen T, Ekblad U, Kero P, et al. Citalopram in pregnancy and lactation. Clin Pharmacol Ther. 2002;72(2):184-191. doi:10.1067/mcp.202.126181 PubMed (Pubitemid 35034496)
7. Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med. 1997;336(4):258-262. doi:10.1056/NEJM197012360404 PubMed (Pubitemid 27044627)
8. Nulman I, Rovet J, Stewart DE, et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry. 2002;159(11):1889-1895. doi:10.176/api.ajp.159.1.189 PubMed (Pubitemid 35283255)
9. Mattson S, Eastvold A, Jones K, et al. Neurobehavioral follow-up of children prenatally exposed to fluoxetine. Teratology. 1999;59:376.
10. Reebye PN, Morison SJ, Panikkar H, et al. Affect expression in prenatally psychotropic exposed and nonexposed mother-infant dyads. Infant Ment Health J. 2002;23(4):403-416. doi:10.102/imhj.1025 (Pubitemid 44767286)
11. Casper RC, Fleisher BE, Lee-Ancajas JC, et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr. 2003;142(4):402-408. doi:10.1067/mpd.203.139 PubMed (Pubitemid 36521227)
12. Oberlander TF, Misri S, Fitzgerald CE, et al. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry. 2004;65(2):230-237. doi:10.408/JCP. v65n0214 PubMed
13. Misri S, Reebye P, Kendrick K, et al. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am J Psychiatry. 2006;163(6):1026-1032. doi:10.176/api.ajp.163.6.1026 PubMed (Pubitemid 44464489)
14. Oberlander TF, Reebye P, Misri S, et al. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Arch Pediatr Adolesc Med. 2007;161(1):22-29. doi:10.101/archpedi.161.1.2 PubMed (Pubitemid 46045459)
15. Pedersen LH, Henriksen TB, Olsen J. Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics. 2010;125(3):e600-e608. doi:10.1542/peds.208-365 PubMed
16. Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry. 2002;159(12):2055-2061. doi:10.176/api.ajp.159.12.205 PubMed (Pubitemid 35423865)
17. Brazelton T, Nugent K. Neonatal Behavioral Assessment Scale. 3rd ed. London, United Kingdom: Mac Keith Press; 1995.
18. Brazelton TB. Neonatal Behavioral Assessment Scale. Clinics in Developmental Medicine. London, United Kingdom: Spastics International Medical Publications; 1973.
19. Suri R, Altshuler LL, Hellemann G, et al. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry. 2007;164(8):1206-1213. doi:10.176/api.ajp.207.0607172 PubMed (Pubitemid 47292409)
20. First MB, Spitzer RL. Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). New York, NY: Biometrics Research, New York State Psychiatric Institute; 1995.
21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
22. Lester BM, Als H, Brazelton TB. Regional obstetric anesthesia and newborn behavior: a reanalysis toward synergistic effects. Child Dev. 1982;53(3):687-692. doi:10.2307/129381 PubMed
23. Engel SM, Zhu C, Berkowitz GS, et al. Prenatal phthalate exposure and performance on the Neonatal Behavioral Assessment Scale in a multiethnic birth cohort. Neurotoxicology. 2009;30(4):522-528. doi:10.1016/j.neuro.209.04.01 PubMed
24. Engel SM, Berkowitz GS, Barr DB, et al. Prenatal organophosphate metabolite and organochlorine levels and performance on the Brazelton Neonatal Behavioral Assessment Scale in a multiethnic pregnancy cohort. Am J Epidemiol. 2007;165(12):1397-1404. doi:10.1093/aje/kwm029 PubMed (Pubitemid 47234308)
25. Morrow CE, Bandstra ES, Anthony JC, et al. Influence of prenatal cocaine exposure on full-term infant neurobehavioral functioning. Neurotoxicol Teratol. 2001;23(6):533-544.